← Eichor
Study identifier: NCT06804980 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

DESIFOR-EXPAND (MHIF)

Condition: Statin Therapy · Statin Adverse Reaction · Statin  ·  Sponsor: Minneapolis Heart Institute Foundation

PhasePhase 4
Planned participants100
Who can joinAll sexes, 21 Years to no upper limit
Healthy volunteersNo

About this study

The DESIFOR pilot study was conducted to determine the feasibility of utilizing an n-of-1 trial to facilitate tolerance of unblinded rosuvastatin in patients with prior statin intolerance

This description comes directly from the study's public registry record.

Talk to the study team

Gretchen Program Director, RDN, CDCES  ·  612-863-3383  ·  Gbenson@mhif.org

Always discuss trial participation with your own doctor first.

Locations (1)

Minneapolis Heart Institute FoundationMinneapolis, Minnesota, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06804980